1

PHARMACEUTICAL

CHALLENGES IN

AFRICA By ADIL ZANFARI, PRESIDENT

EAHIC London

FROM AFRICANS TO AFRICANS

A PRAGMATIC VISION ABOUT THE FUTURE OF PHARMACEUTICAL INDUSTRY IN AFRICA

THE MOROCCAN CASE

The Moroccan Pharmaceutical Market: a high potential industry in motion

• 32 pharmaceuticals industrial plants

• 300 millions units manufactured in 2011

• 6000 products presentations marketed

• 65% of total medicines consumed are produced locally

• + 40 000 direct and indirect employment

• 2012 Private market : 1 billion USD

• 2013 Tender market : 300 millions USD

• 2011 Export pharmaceutical market : 45 millions USD

• 40 export Countries in Africa, Middle East, Europe

• Morocco included into the European pharmaceutical Zone

• EDMQ European Pharmacopoeia applied

• Morocco National Control Laboratory ( LNCM ) is the only African member of the European network of official medecine Control laboratories ( OMCLs EDMQ )

The EMERGENCE Plan: the Morocco Government industrial strategy to strengthen country attractiveness

• Launched in 2007 to magnify the competitive advantages of Morocco over other developing countries

• 2 Main strategic goals:

Accelerate the creation of sustainable added value wealth

Build up powerful industrial activities to boost-up exports

• 8 specific industries covered:

Offshoring

Automotive

Electronics

Aeronautic

Agro food

textile / leather

Pharmaceutical Industry

Chemistry

KEY ISSUE => PHARMACEUTICAL INDUSTRY IS INCLUDED SINCE 20 FEBRUARY 2013

Moroccan Government

National Association of Generic Pharmaceutical Producers

Pharmacists Medical Doctors

PHARMACEUTICAL INDUSTRY HAS BEEN ADDED IN THE EMERGENCE PLAN IN 2013 !

The Pharmaceutical industry is now fully part of the strategic investment plan

The EMERGENCE Plan for Pharmaceutical industry: a collective & focused approach

to unleash the local potential

Partnership between Private sector & Public sector

First class international and national consulting firms involved

One strong Objective: Develop access to affordable medicines

Key Target : Accelerate both local market growth and export development

Milestone 1: Achieve 1 to 2 billion USD sales in Pharma Export by 2023

Milestone 2: Increase local pharma market from 1 to 2 billion USD by 2023

Targeted outcome 1: Create + 5,000 additional direct employement

Targeted outcome 2: Create + 15,000 – 20,000 indirect employement

The Pharmaceutical EMERGENCE plan translates into a multidimensional approach

to improve National health system

Main Goal: Strengthen the ability of National Health system to address the

needs of Moroccan population

Strengthen & upgrade the local pharmaceutical industry to match USD FDA, AFSAPS, TGA, UK MHRA, MCC & GCC certifications

Develop outsourcing R&D

Develop Manufacturing

offshoring (CMO)

Increase impact of Generics through Export to Africa &

Middle East

Develop Clinical trials programs

(CRO)

Attract mid size Pharma companies

to relocate production in

Morocco

Launch large scale training &

education of pharma teams Upgrade local

legislation to match European pharma rules

Dedicate investment funds to sponsor the project (100 M USD)

The Pharmaceutical EMERGENCE plan is also seeking growth through targeting 4 key segments representing a total potential of

100 Million USD

In fact the Pharmaceutical EMERGENCE plan constitutes a strong lever to

accelerate cost effective achievement of competitive economy of scale

ECONOMY OF SCALE: A KEY INGREDIENT TO SECURE AFFORDABLE DRUGS TO POPULATION !

11

www.genpharma.ma

254 – 260 ZI 24000 EL JADIDA MOROCCO

Tel : +212 523 35 29 83 FAX: +212 523 35 29 93